ESR1 and breast cancer: Restoration of miR-145 expression can efficiently increase apoptosis in BC cells expressing wild-type TP53 or estrogen receptor, implying that miR-145 therapy may be helpful in patients with BCs expressing wild-type TP53 or estrogen receptor [49].